Biosergen Gets Approval for Nasdaq First North Growth Market Delisting

MT Newswires · 3d ago
11:30 AM EDT, 09/17/2026 (MT Newswires) -- Biosergen (BIOSGN.ST) secured approval to delist from Nasdaq First North Growth Market, with its final trading day set for Oct. 21, according to a Thursday release. The application follows the biotechnology company's planned merger with life science investor Flerie (FLERIE.ST), which is conditional on the Swedish Companies Registration Office's approval, expected around Oct. 15. Registration is set to follow on Oct. 23.